![Benjamin Lane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 M $ al 31/05/2026
Dr. Benjamin Lane is a Chief Technical Operations Officer at Nuvalent, Inc. He received his doctorate degree from Texas A&M University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NUVALENT, INC. CLASS A 0,07 % | 01/04/2026 | 50.368 ( 0,07 % ) | 6 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NUVALENT, INC. | Director de Operaciones | 20/07/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
